Articles with public access mandates - Paul GrootendorstLearn more
Not available anywhere: 5
Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research
KM Johnston, P Gustafson, AR Levy, P Grootendorst
Statistics in medicine 27 (9), 1539-1556, 2008
Mandates: Canadian Institutes of Health Research
Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology
Y Li, MR Abbaspour, PV Grootendorst, AM Rauth, XY Wu
European Journal of Pharmaceutics and Biopharmaceutics 94, 170-179, 2015
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
The 2011 Canada-European Union Comprehensive Economic and Trade Agreement: an economic impact assessment of the EU’s proposed pharmaceutical intellectual property provisions
P Grootendorst, A Hollis
Journal of Generic Medicines 8 (2), 81-103, 2011
Mandates: Canadian Institutes of Health Research
Impact of age, hypercholesterolemia, and the vitamin D receptor on brain endogenous β‐amyloid peptide accumulation in mice
HB Peng, P Bukuroshi, MR Durk, P Grootendorst, X Yan, SR Pan, ...
Biopharmaceutics & Drug Disposition 42 (8), 372-388, 2021
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Canada's contribution to global research in cardiovascular diseases
HV Nguyen, C de Oliveira, HC Wijeysundera, WWL Wong, G Woo, ...
Canadian Journal of Cardiology 29 (6), 742-746, 2013
Mandates: Canadian Institutes of Health Research
Available somewhere: 21
The cost of drug development: a systematic review
S Morgan, P Grootendorst, J Lexchin, C Cunningham, D Greyson
Health policy 100 (1), 4-17, 2011
Mandates: Canadian Institutes of Health Research
Economic instruments for obesity prevention: results of a scoping review and modified Delphi survey
GEJ Faulkner, P Grootendorst, VH Nguyen, T Andreyeva, ...
International Journal of Behavioral Nutrition and Physical Activity 8, 1-14, 2011
Mandates: Heart and Stroke Foundation of Canada
Equity in dental care among Canadian households
C Quiñonez, P Grootendorst
International Journal for Equity in Health 10, 1-9, 2011
Mandates: Canadian Institutes of Health Research
Effect of the Low Risk Ankle Rule on the frequency of radiography in children with ankle injuries
K Boutis, P Grootendorst, A Willan, AC Plint, P Babyn, RJ Brison, A Sayal, ...
Cmaj 185 (15), E731-E738, 2013
Mandates: Canadian Institutes of Health Research
Estimating chronic hepatitis C prognosis using transient elastography‐based liver stiffness: a systematic review and meta‐analysis
A Erman, A Sathya, A Nam, JM Bielecki, JJ Feld, HH Thein, WWL Wong, ...
Journal of viral hepatitis 25 (5), 502-513, 2018
Mandates: Canadian Institutes of Health Research
Validation of six short and ultra-short screening instruments for depression for people living with HIV in Ontario: results from the Ontario HIV treatment network cohort study
SKY Choi, E Boyle, AN Burchell, S Gardner, E Collins, P Grootendorst, ...
PloS one 10 (11), e0142706, 2015
Mandates: Canadian Institutes of Health Research
Cost consequence analysis of implementing the low risk ankle rule in emergency departments
K Boutis, C von Keyserlingk, A Willan, UG Narayanan, R Brison, ...
Annals of Emergency Medicine 66 (5), 455-463. e4, 2015
Mandates: Canadian Institutes of Health Research
Factors associated with drug shortages in Canada: a retrospective cohort study
W Zhang, DP Guh, H Sun, LD Lynd, A Hollis, P Grootendorst, AH Anis
Canadian Medical Association Open Access Journal 8 (3), E535-E544, 2020
Mandates: Canadian Institutes of Health Research
Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis
C de Oliveira, HV Nguyen, HC Wijeysundera, WWL Wong, G Woo, ...
Canadian Medical Association Open Access Journal 1 (2), E83-E90, 2013
Mandates: Canadian Institutes of Health Research
The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach
A Erman, WWL Wong, JJ Feld, P Grootendorst, MD Krahn
Liver International 40 (1), 51-59, 2020
Mandates: Canadian Institutes of Health Research
Economic evaluation of vaccines in Canada: A systematic review
A Chit, JKH Lee, M Shim, VH Nguyen, P Grootendorst, J Wu, R Van Exan, ...
Human vaccines & immunotherapeutics 12 (5), 1257-1264, 2016
Mandates: Canadian Institutes of Health Research
The impact of tiered-pricing framework on generic entry in Canada
W Zhang, H Sun, DP Guh, LD Lynd, A Hollis, P Grootendorst, AH Anis
International Journal of Health Policy and Management 11 (6), 768, 2022
Mandates: Canadian Institutes of Health Research, Michael Smith Foundation for Health …
Differences in incremental cost-effectiveness ratios for common versus rare conditions: a case from oncology
K Jayasundara, M Krahn, M Mamdani, JS Hoch, P Grootendorst
PharmacoEconomics-open 1, 167-173, 2017
Mandates: Canadian Institutes of Health Research
Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review
N Konstantelos, AM Rzepka, AM Burden, AM Cheung, S Kim, ...
Osteoporosis International 33 (9), 1837-1844, 2022
Mandates: Canadian Institutes of Health Research, World Health Organization
Modeling tiered pricing frameworks: A simulation approach
J Moradpour, W Zhang, P Grootendorst, AH Anis, A Hollis
Value in Health 26 (3), 351-358, 2023
Mandates: Canadian Institutes of Health Research
Publication and funding information is determined automatically by a computer program